COVID-19: UK research shows tocilizumab can reduce the risk of death

The internationally-renowned RECOVERY trial has recently released a preprint manuscript showing that the rheumatoid arthritis drug tocilizumab can reduce the risk of dying from COVID-19.

SARS-CoV-2 virus (COVID-19). Image source: Pixabay

The RECOVERY trial is a large randomized controlled trial platform that has been used to evaluate several potential treatments for COVID-19. They’ve already been…